3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
niraparib
2
anlotinib
2
Paclitaxel
2
Carboplatin
2
Bevacizumab
2
temsirolimus
1
olaparib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Trabectedin
1
Robotic Surgical Procedures
1
Pregnancy Tests
1
Ocoxin
1
Laparoscopy
1
Human Papillomavirus DNA Tests
1
GX-188 vaccine
1
Filgrastim
1
Diffusion
1
Dexamethasone
1
Colposcopy
1
CP protocol
1
Biopsy
1
Acetic Acid
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Diseases, Female
×
Pregnancy Tests
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled